Newsletter May 2024 No.221
Top News
The 35th Pharmaceutical Manufacturers Association of Japan (PMAJ) Policy Seminar" was held on March 4, 2024. While drug prices are under intense scrutiny in order to curb rising social security costs, healthcare policy is being asked to take a difficult turn, as highly effective but expensive biopharmaceuticals are introduced one after another. At the same time, there is a growing need for a mechanism to efficiently produce such innovative drugs in Japan. At this policy seminar, through lectures and panel discussions by experts from various fields, many proposals were made on how to balance the maintenance of the universal health insurance system and the enhancement of drug discovery in order to provide sustainable health care to the people. The following is a transcript of the seminar.
Topics
- The event to raise awareness of pharmaceutical and medical issues, "Living with Disease. Living with Hope. Photo Exhibition" was held.
- Held the "Meeting of Compliance Managers and Practitioners for 2023
- Holding of "The Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum" Considering the various values brought by pharmaceuticals - For the affluent daily life that patients and their families desire
- Held the "World NTD Day 2024: The First Neglected Tropical Diseases Student Contest and Online Event
- 2024 Life Science Intellectual Property Forum" Held Now is the Time to Strengthen Japan's Drug Discovery Capability! ～Aiming to Build a Robust Drug Discovery Ecosystem for New Modalities
- The 10th Japan-Thailand Joint Symposium" held
- Briefing session on the revision of the cost-effectiveness evaluation system in 2024.
Policy Research Institute page
The Current State of Japanese Academia from the Perspective of Research Power
From JPMA
Toward Building a Drug Discovery Ecosystem Suitable for Japan